Concord Drugs
CONCORDBSE

Concord Drugs

₹73.021.01 (1.40%)1D
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
73.00
Today’s high
75.61
52 week low
27.46
52 week high
92.52
Open price
74.80
Previous close
72.01
Live volume
17,221
Lower circuit
69.37
Upper circuit
76.67

Fundamentals

Market Cap
₹72Cr
ROE
1.67%
P/E Ratio(TTM)
126.33
EPS(TTM)
0.57
P/B Ratio
2.09
Dividend Yield
0.00%
Industry P/E
32.40
Book Value
34.42
Debt to Equity
0.50
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Concord Drugs Limited is an Indian pharmaceutical company where the management is committed to achieving excellence through comprehensive quality management in all its operations. The company's strategic focus is on creating innovative drug delivery systems, including technologies like Sustained Release and Modified Release pellets, using the latest processes. It runs a state-of-the-art cGMP contract manufacturing facility, offering a full range of services for pharmaceutical development and drug product manufacturing. The company has also established robust internal financial controls to ensure the safety of its assets and the reliability of its financial transactions. Its main strength lies in delivering complete end-to-end solutions to customers and partners with its Ready-to-Fill Pellets and Finished Pharmaceutical Formulations. This positions Concord among a select few Indian pharmaceutical companies with a cutting-edge WHO-GMP certified facility, enabling the production of superior quality products.;
MD/CEO
Mr. S. Nagi Reddy
Founded in
1995
BSE symbol
538965

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
54.39%
Retail And Others
45.61%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,070.40
+18.60 (0.91%)
L
    H
    32,944.2443.78.66
    ₹1,453.40
    -13.50 (0.92%)
    L
      H
      27,833.6431.15.87
      WockhardtWOCKPHARMA
      ₹1,305.20
      +14.90 (1.15%)
      L
        H
        21,058.17-2090.244.61
        Natco PharmaNATCOPHARM
        ₹1,000.80
        +47.70 (5.00%)
        L
          H
          17,065.5910.971.97
          2026
          14
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          8
          Aug
          Quarterly Result
          Release date
          23
          May
          Annual Result
          Release date
          11
          Jan
          Quarterly Result
          Release date
          2024
          13
          Nov
          Quarterly Result
          Release date
          9
          Aug
          Quarterly Result
          Release date
          30
          May
          Annual Result
          Release date
          25
          May
          Result
          Release date
          Events calendar
          View upcoming events in other stocks